BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 7974169)

  • 1. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia.
    von Ardenne M
    Strahlenther Onkol; 1994 Oct; 170(10):581-9. PubMed ID: 7974169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of systemic tolerance of 42.0 degrees C infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. A Phase-I study.
    Steinhausen D; Mayer WK; von Ardenne M
    Strahlenther Onkol; 1994 Jun; 170(6):322-34. PubMed ID: 8023241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study.
    Hildebrandt B; Dräger J; Kerner T; Deja M; Löffel J; Stroszczynski C; Ahlers O; Felix R; Riess H; Wust P
    Int J Hyperthermia; 2004 May; 20(3):317-33. PubMed ID: 15204528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole body hyperthermia: a secure procedure for patients with various malignancies?
    Kerner T; Deja M; Ahlers O; Löffel J; Hildebrandt B; Wust P; Gerlach H; Riess H
    Intensive Care Med; 1999 Sep; 25(9):959-65. PubMed ID: 10501752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences.
    Wehner H; von Ardenne A; Kaltofen S
    Int J Hyperthermia; 2001; 17(1):19-30. PubMed ID: 11212877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Whole-body artificial controlled hyperthermia and hyperglycemia in the combined treatment of metastatic kidney cancer].
    Mavrichev AS; Fradkin SZ; Zhavrid EA; Nodel'son SE; Rovbut' II
    Urol Nefrol (Mosk); 1990; (3):48-52. PubMed ID: 2396340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Whole-body hyperthermia and hyperglycemia in the combined treatment of rectal cancer].
    Kulemin VV; Al'bitskiĭ VB; Kotomin SV; Varigin IuA
    Med Radiol (Mosk); 1987 Jan; 32(1):50-2. PubMed ID: 3543598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice.
    Udagawa Y; Nagasawa H; Kiyokawa S
    Anticancer Res; 1999; 19(5B):4125-30. PubMed ID: 10628363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole body hyperthermia in the treatment of neoplastic disease.
    Robins HI; Hugander A; Cohen JD
    Radiol Clin North Am; 1989 May; 27(3):603-10. PubMed ID: 2648462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'.
    Hildebrandt B; Hegewisch-Becker S; Kerner T; Nierhaus A; Bakhshandeh-Bath A; Janni W; Zumschlinge R; Sommer H; Riess H; Wust P;
    Int J Hyperthermia; 2005 Mar; 21(2):169-83. PubMed ID: 15764358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and analysis of thermal parameters for the whole-body-hyperthermia system IRATHERM-2000.
    Wust P; Riess H; Hildebrandt B; Löffel J; Deja M; Ahlers O; Kerner T; von Ardenne A; Felix R
    Int J Hyperthermia; 2000; 16(4):325-39. PubMed ID: 10949129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with therapeutic whole-body hyperthermia].
    Eisler K; Landauer B; Hipp R; Kolb E; Lange J; Siewert JR; Zänker K; Blümel G
    Anaesthesist; 1985 Jun; 34(6):299-303. PubMed ID: 4061805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of a radiculopathia by whole-body hyperthermia].
    Schencking M; Frese T; Sandholzer H
    Forsch Komplementmed; 2008 Oct; 15(5):273-6. PubMed ID: 19001825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
    Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles and 1977 concept of cancer multistep therapy. Physiological fundamentals of the new timing. Selectotherm local hyperthermy (author's transl)].
    von Ardenne M
    Arch Geschwulstforsch; 1978; 48(6):504-20. PubMed ID: 31849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.
    Atanackovic D; Nierhaus A; Neumeier M; Hossfeld DK; Hegewisch-Becker S
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):603-13. PubMed ID: 12439605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Addition of hyperthermia. Heat potentiates cancer therapy].
    Hegewisch-Becker S; Hossfeld DK
    MMW Fortschr Med; 2001 Jun; 143(25):28-32. PubMed ID: 11468993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body hyperthermia supplemented with urotropin in the treatment of malignant tumors.
    Ismail-Zade RS
    Exp Oncol; 2005 Mar; 27(1):61-4. PubMed ID: 15812360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.